EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.2.2.6 | Multiple Myeloma |
33396591 |
Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells. |
unassigned |
0 |
| 3.2.2.6 | Myocardial Ischemia |
12111041 |
Myocardial ischemia and reperfusion reduce the levels of cyclic ADP-ribose in rat myocardium. |
unassigned |
0 |
| 3.2.2.6 | Neoplasms |
11208895 |
Cyclic ADP-ribose as a potential second messenger for neuronal Ca2+ signaling. |
unassigned |
0 |
| 3.2.2.6 | Neoplasms |
11399650 |
cADP-ribose/ryanodine channel/Ca2+-release signal transduction pathway in mesangial cells. |
unassigned |
0 |
| 3.2.2.6 | Neoplasms |
15761615 |
Changes in NAD/ADP-ribose metabolism in rectal cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
4
2
0 |
| 3.2.2.6 | Neoplasms |
17852458 |
Erythrocyte CD38 as a prognostic marker in cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
3
1 |
| 3.2.2.6 | Neoplasms |
33727923 |
CD38 and Regulation of the Immune Response Cells in Cancer. |
causal interaction
unassigned |
4
0 |
| 3.2.2.6 | Nervous System Diseases |
19907741 |
Role of ADP-ribosyl cyclase in the pathogenesis of neurological disorders after coronary artery bypass surgery and experimental ischemia. |
therapeutic application
unassigned |
3
0 |
| 3.2.2.6 | Neuroblastoma |
9395453 |
Muscarinic receptor-mediated dual regulation of ADP-ribosyl cyclase in NG108-15 neuronal cell membranes. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
3
2
1 |
| 3.2.2.6 | Neuroblastoma |
11258666 |
Signal transduction from bradykinin, angiotensin, adrenergic and muscarinic receptors to effector enzymes, including ADP-ribosyl cyclase. |
ongoing research
unassigned |
3
0 |
